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Abstract
The mos protooncogene encodes a serine/threonine kinase
and is a key regulator of oocyte meiotic maturation. After
acute infedion of Swiss 3T3 cells with virus containing the
v-mos oncogene, cells expressing high levels of v-Mos
round up and detach from the monolayer (floating cells),
while cells that remain attached express 10-fold lower
levels of v-Mos and are transformed. The floating cells are
growth arrested with their chromosomes partially con-
densed in the absence of histone Hi kinase adivity, while
mitogen-adivated protein kinase adivity is very high. Col-
lectively, these properties are similar to properties ob-
served in maturing oocytes between meiosis I and II. In
v-mos-transformed cell populations, mitogen-adivated
protein kinase adivity is also elevated, correlating with the
degree of morphological transformation and the level of
Mos expression. Moreover, phosphoprotein modifications
specific for M are found in both the floating cells and in
v-mos-transformed cells, regardless of their cell cycle
stage. One explanation for both morphological transfor-
mation and the phenotypes of the floating cells is that Mos
imposes a meiotic program on different stages of the so-
matic cell cycle. The extent of this meiotic phenotype is
proportional to the level of v-Mos expression. These results
suggest that both morphological transformation and the
phenotypes of the floating cells induced by Mos in Swiss
3T3 cells are related to its normal adivities during oocyte
maturation.
Introduction
The mos gene was originally identified as an acquired
cellular sequence carried by the acute transforming retro-
virus, Mo-MuSV3 (i-4). Recombinant v-mos, under a pro-
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viral long terminal repeat promoter, was the first oncogene
shown to transform cells efficiently in DNA transfection
assays (5-7). Similarly, the murine cellular homologue,
c-mos’￿, under long terminal repeat control was shown to
transform cells efficiently (4, 5), demonstrating that v-Mos
and c-Mos have essentially the same biological activities
and that inappropriate expression of the mos protoonco-
gene in fibroblast cells is sufficient to cause morphological
transformation (3, 4, 8, 9).
The c-mos protooncogene product is normally expressed
in germ cells (iO) and is required throughout oocyte matu-
ration in Xenopus to activate MPF (11-18). Mos has also
been identified as an active component of cytostatic factor
(1 9), an activity associated with the arrest of oocyte matu-
ration at metaphase of meiosis II, the state corresponding to
an unfertilized egg (20). Thus, Mos is a key regulator of
meiosis and the production of unfertilized eggs. Mos has
been shown to associate with tubulin in vitro and the spin-
dIe and the spindle poles in vivo, suggesting that Mos
contributes to meiotic microtubule reorganization (21 , 22).
MAPK has also been implicated in meiotic microtubule
reorganization (23) and has been shown to localize to
MTOCs during meiosis (24). Recently, Mos has been shown
to activate MAPK in vivo and in vitro in Xenopus oocytes or
cell-free extracts (25, 26).
Acute infection of Swiss 3T3 cells with Mo-MuSV that
contains the v-mos protooncogene causes a large percent-
age of the cells to round-up and detach from the monolayer
(floating cells; Refs. 27 and 28), and only the cells that
remain attached grow as morphologically transformed
cells. We have shown that approximately 70% of the float-
ing cells are growth arrested with 2C or 4C DNA content.4
The cells with 4C DNA content are binucleated and have
undergone nuclear division without cytokinesis.4 In this
study, we further characterized Swiss 3T3 cells overexpress-
ing or transformed by v-Mos and show, in the floating cells,
partial chromosomal condensation in the absence of Hi
kinase activity. Furthermore, phosphoprotein modifications
that are specific to M in nontransformed cells are detected
in the floating cells and in v-mos-transformed cells inde-
pendent of the cell cycle stage.
Results
Morphological Transformation and v-Mos Expression. To
obtain high levels of Mos expression in somatic cells, we
infected Swiss 3T3 cells with Mo-MuSV containing the
v-mos oncogene. Control cells were either mock-infected
or infected with helper Mo-MuLV. As previously reported,
60-70 h P.1., the majority of Mo-MuSV-infected cells (70-
90%) round up and detach from the monolayer as floating
ered saline; SDS-PAGE, sodium dodecyl sulfate-gel electrophoresis; TBS,
Tris-buffered saline; DTT, dilhiothreitol; PMSF, phenylmethylsulfonyl fluo-
ride.
4 K. Fukasawa and G. F. Vande Woude, submitted for publication.kDa
46 -
1 2 3 4
￿ , , I
A
B
5 6 7 8
￿ ...
30- ￿ 1!,
0’
￿J .. -
. , . ..-, . - -
. . - , .. ￿ .
‘, - .
1094 rnos-incluced M-phase Phenotypes in Somatic Cells
C .- ￿￿sVa￿> ￿
.￿. % .. . . ￿- - .. .,
￿ -: - ￿ . ,￿-￿--#{149}---.-.-- #{163}￿ ￿ -￿
￿
. .; (. . . ￿ ￿-:. -:_ ￿ ￿
￿ “-I ￿ ￿. . (￿ ￿ ‘ ￿ :￿ .￿ ￿4￿r￿:’,.:d4￿
; ￿ c-.￿ ￿
“i:,’’ , :-￿‘ ￿
. ..￿ . .- ￿ -￿￿:
:, , ,. .
.- .7’ 1
.￿.- v-mos
.￿- c-mos
Fig. 1. The immunoblot analysis
of v-Mos expression in cells in-
fected with Mo-MuSV and pho-
tomicrographs of cloned v-mos
transformed cell lines. A, cell cx-
tracts containing -￿ 100 pg of total
proteins were run on a i0”/￿ SOS-
PAGE and transferred onto Immo-
bilon (Millipore( sheets. The blots
were then prc)bed with anti-Mos”
polyclonal antibody ZC-75. Anti-
body-antigen complex was de-
tected with alkaline phospha-
tase-conjugated anti-rabbit IgG
antibody, followed by reaction
with bromochloroinclolyl phos-
phate-nitroblue letrazolium (Bio-
Rad(. Lane 1, control Mo-MuLV-
infected cells; Lane 2, PTS1
c-rnos” transformed cell line;
Lane 3, floating cells; Lane 4, Mo-
MuSV-infectecl cells that remain at-
tached to the dish 40 h P.1.; Lane 5,
Mo-MuSV-infected cells that re-
main attached to the dish 70 h P.1.;
Lane 6, Tx3 line; Lane 7, Tx2 line;
Lane 8, Txi line. B, cells grown in
culture dish were directly photo-
graphed using an inverted niicro-
scope. a, control Swiss 3T3 cells; b,
Txi cells; c, Tx2 cells; d, Tx3 cells.
x 100.
cells.4 Approximately 70% of floating cells exclude trypan
blue but do not proliferate, while the remaining cells are
dead or dying (27).￿ Only the cells that remain attached
grow as foci of morphologically transformed cells. We
cloned several cell populations from these foci, and three
clones were chosen for further study (Txi , Tx2, and Tx3).
The level of v-Mos in the floating cells is - 0.1 % of total
protein (Fig. 1A, Lane 3), which is -10-fold higher than in
the Mo-MuSV-infected cells that remain attached at 40 h
P.1. (Fig. 1A, Lane 5) and 60-70 h P.1. (Fig. 1A, Lane 4). The
level of p39fllO￿ expression in PTS1 c￿mos￿￿u￿transformed
cells is barely detectable (Refs. 15 and 29; Fig. 1A, Lane 2).
As expected, the mobility of c-Mos is faster than v-Mos,
which contains 26 extra NH,-terminal amino acids (8).
Among the cloned v-mos transformants, Tx3 cells express
the highest level of v-Mos (Fig. 1A, Lane 6) and show the
greatest morphological alteration (Fig. 1 B, d), while Txl
cells express the lowest level of v-Mos (Fig. 1A, Lane 8) and
are least transformed (Fig. 1B, b). The Tx2 cells are inter-
mediate both in v-Mos expression and transformed pheno-
type (Figs. 1A, Lane 7and 18, c). Moreover, the efficiency
of anchorage-independent colony formation in soft agar of
the v-mos-transformed cell lines also correlates with the
level of v-Mos expression; the average CFE (the ratio of the
number of soft agar colonies to the number of viable cells
plated) from two independent experiments was 0.001 for
Swiss 3T3 cells, 0.1 3 for Txl cells, 0.24 for Tx2 cells, and
0.42 for Tx3 cells. These results confirm earlier studies
correlating v-Mos overexpression with somatic cell toxicity
(30) but also show that the degree of morphological trans-
formation correlates directly with the level of Mos expres-
sion.
Partial Chromosomal Condensation Induced by High
Level Expression of v-Mos in the Absence of Histone Hi
Kinase Activity. The majority of the viable floating cells,
both cells arrested at 2C and 4C DNA content, contained.
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Fig. 2. Inappropriate chromosomal condensation in the floating cells re-
suIted troni v-Mos overexpression. The viable floating cells, isolated after
Peroll gradient separation of viable cells from dead or dying cells, were
seeded onto ,￿ slick’ and examined at X 630. Control cells were grown on
coverslips. After fixation with 1.7/,, formaldehyde, cells were stained with
DAPI. A. iriterphase control IT I cell; B. control 3T3 cell in mitosis; Cancl 0,
floating ( elk.
Fig. .3. The influence of v-Mos expression on H 1 histone kinase activity and
its components, p34’ ‘￿‘ 2 and cyclin B. A, cell extracts were precipitated with
p1 3” ‘ beads. The beads were subjected to histone Hi kinase analysis as
described in “Materials and Methods.” Control IT.) cells (Lane 1(, nococla-
zole-arrested M-phase control 3T3 cells (Lane 2), floating cells (Lane fl, and
Tx3 v-mos-transformed cells (Lane 4(. The dead or dying cells were removed
from the floating cells by Percoll gradient centrifugalion prior to the prepa-
ration of lysates. B, p34’’￿’ ￿ cell extracts containing ￿-50 pg of total protein
were sul)jectedl to iO”/,, SDS-PAGE and Iransferrecl onto Imniobilon (Milli-
Pore( sheets. The blots were probedl with anti-p34’ ‘￿ ‘￿ COOH-terminal
monoclonal antibody (Santa Cruz(, and anlil)odly-antigen complexes were
dletecled with alkaline phosphatase-conjugateci anti-mouse lgG antibody, as
dlescril)edf in the Fig. 1 legend. The samples in Lanes 1-4 are as in (A(. C,
cyclin B: immunoblots, prepared as dlescribedl in (B), were I)rOIR’dI with
anti-cyclin B Polyclonal antibody (Santa Cruz), and antibody-antigen coni-
plexes were detected with horseradish peroxidase-conjugateci anti-rabbit
lgG and visualized by chemiluminescent reactions as reconimencleci (Am-
ersham(. The samples in Lanes 1-3 are as in (A). 0, cyclin B in p34’ ‘￿
immunoprecipitates: p34’ ￿ ￿ was immunoprecipitated with anti-p34’ “
COOH-terminal monoclonal antibody (Santa Cruz( from control 3T3 cells
(Lane 1), nococlazole-arrestecl M-phase 313 cells (Lane 2), andl floating cells
(Lane I). After extensive washing with lysis I)uffer, the immunoprecipitates
were resolved on a 10/ SDS-PAGE and transferred onto Immobilon (Milli-
pore) sheets. The immunoblots were then probe(1 with anti-cyclin B antibody
as described (C) and visualized by chemiluminescent reactions.
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partially condensed chromosomes as revealed with DAPI
DNA stairting (Fig. 2, C and D, and data not shown)4 and
resemble the state of condensation observed in control
Swiss 3T3 cells only during prophase (Fig. 2B). Interphase
control cells stained with DAPI do not show condensation
(Fig. 2A).
It has been shown that ￿34￿f￿2 kinase induces chromo-
somal condensation (31 , 32). Since Mos indirectly activates
and stabilizes MPF (19), we assayed the floating cells for
p34((f(2 kinase activity by measuring Hi histone kinase
activity (Fig. 3A). pi3￿’1 bead-precipitated extracts from
nocodazole-treated M-arrested Swiss 3T3 cells displayed
high levels of histone Hi kinase activity (Fig. 3A, Lane 2).
In contrast, extracts from unsynchronized control Mo-
MuLV-infected and v-Mos-transformed cell populations, in
which only a fraction of the cells are in M, displayed the
expected low levels of activity (Fig. 3A, Lanes 1 and 4).
Surprisingly, extracts from floating cells lacked detectable
histone Hi kinase activity (Fig. 3A, Lane 3). Although v-
Mos-induced chromosome condensation could have re-
suIted from transient p34￿th2 activation, these results show
that the activation of p34”t’ ￿ is not required for the main-
tenance of the chromosome condensation or growth arrest.
States of p34cdc2 and Cyclin B in the Floating Cells. We
further examined the floating cell population to determine
whether p’t’ 2 was dephosphorylated and if cyclin B was
present. We used an antibody directed to the COOH ter-
nlinus of ￿ 2 in immunoblot analyses. Control 3T3 cells
in M (Fig. 3B, Lane 2) showed only the expected single
active form of p34((f(2, while actively growing control cells
and Tx3 cells displayed additional, slower-moving phos-
phorylated fornis (Fig. 3B, Lanes 1 and 4, respectively).
Only the dephosphorylated form of p34’￿ ￿ was detected in
the floating cells (Fig. 3B, Lane 3). Even though histone Hi
kinase activity was not detected (Fig. 3A), cyclin B was
unexpectedly found in the floating cells at levels similar to
control cells in M (Fig. 3C, compare Lanes 2 and 3). More-
over, cyclin B was not found in anti-p34￿’￿2 immunopre-
cipitates from the floating cells but was coprecipitated with
p34((l( 2 from M-arrested control cells (Fig. 3D). We are not
certain why cyclin B is not associated with p34￿’2 in the
floating cells, but a similar result was observed previously in
Mos-transformed NIH3T3 cells (33).
MAPK Activity in Somatic Cells Expressing Mos. Mos
has been implicated in MAPK activation during meiosis (25,0.
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Fig. 4. MAPK activation in cells expressing v-Mos. Control 3T3 cells (Lane 1); v-raf-transformed 3T3 cell line (BxB; Lane 2); floating cells (Lane 3);
v-mos-transformed cell lines, Tx3 (Lane 4); Tx2 (Lane 5); Txl (Lane 6). The dead or dying cells were removed from the floating cells prior to the preparation of
lysates. The v-raf-transformed 3T3 cell line with constitulively activated MAPK was included as a positive control (Lane 2). MBP phosphorylation was analyzed
by 18% SDS-PAGE, followed by autoradiography (upperpanel). The kinase activity was also quantitated by scintillation counting, and the data is presented in
bar graphs (lower panel). The lane designations of the auloradiograph and bar graph are the same.
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26), and the level of MAPK activity is significantly higher
during meiosis than during mitosis in one-cell mouse em-
bryos.5 In nontransformed somatic cells, MAPK is activated
only after mitogenic stimulation in G1 (34-38) and is re-
ported to increase slightly at G2-M (39). Here, we examined
the relationship between the level of MAPK activity, the
level of v-Mos, and the degree of morphological transfor-
mation. MAPK activity was determined in vitro using MBP
as a substrate (Fig. 4). MBP phosphorylation was not de-
tected in MAPK precipitates from control Swiss 3T3 cells
maintained for 36 h in 0.5% serum (Fig. 4, Lane 1), while
the floating cells and the v-mos-transformed cell lines
(Txi-3) displayed high levels of MBP phosphorylation ac-
tivity (Fig. 4, Lanes 4-6). The level in Tx3 cells is similar to
the level detected in raf-i -transformed cells (Fig. 4, Lane 2).
These analyses show that MAPK activity correlates with the
level of Mos expression as well as with the extent of mor-
phological transformation (compare with Fig. 1 ). Moreover,
MAPK activation in the floating cells and transformed cells
is constitutive in 0.5￿/￿ serum and occurs in the absence of
mitogenic stimulation.
Similarities of Phenotypes between the Eloating Cells
and Oocytes during Meiotic lnterphase. Low histone Hi
ki nase activity, chromosome condensation, dephosphory-
lated p34cdc2, the presence of cyclin B, and the activation
of MAPK in the floating cells are reminiscent of the prop-
erties of amphibian and mammalian oocytes during meiotic
interphase, the period between meiosis I and meiosis II. In
Xenopus oocytes during meiotic interphase, MPF is low
(Ref. 40; Fig. 5, A and D), while cyclin B is present (4i , 42)
and p34cdc2 remains dephosphorylated (Fig. SB). By mo-
bility shift, MAPK remains activated throughout meiosis
including meiotic interphase (Fig. 5, C and 0). Activated
MAPK is also detected during meiotic interphase by in vitro
kinase assays using anti-MAPK monoclonal antibody and
MBP as a substrate (Fig.SD).
The Role of Mos and MAPK in Mos-transformed Cells.
The role ofMAPK in gene regulation during G1 (reviewed in
Refs. 43-46) is quite different from its proposed role in
microtubule reorganization during meiosis (23, 24). We
have proposed that Mos induces, during meiosis, microtu-
bule reorganization and that this activity is responsible for
the transformed phenotype (47). Therefore, we examined
the microtubule organization in the floating cells and
v-mos-transformed cells by immunostaining with anti-a-
tubulin antibody (DMiA; Fig. 6A). Compared with control
Swiss 3T3 cells, the microtubule organization in the floating
cells and in the v-mos-transformed cells was significantly
disrupted (Fig. 6A, b and c). We also examined the floating
cells and v-mos-transformed cells with the monoclonal an-
tibody ZSK2 (Zymed) that was originally prepared against
rat brain tubulin. Surprisingly, the ZSK2 antibody only
stained the spindle of Swiss 3T3 control cells in M, while
cells in interphase were not efficiently stained (Fig. 6B, a-c).
However, ZSK2 stained the floating cells and v-mos-trans-
formed cells intensely and, more importantly, independent
of the cell cycle stage (Fig. 6B, g-j). These results showed
that the ZSK2 antibody preferentially reacted with M-spe-
cific epitopes in nontransformed cells and provided evi-
dence that these epitopes were constitutively present in
cells expressing v-Mos. The antigens detected in immuno-01 20V21 2345 6 (h)
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Fig. 5. Analysis of Hi histone ki-
nase and MAPK activities during
the meiotic interphase of Xenopus
OOcytes. Stage VI oocytes, prepared
as described) in “Materials and
Methodls,” were induced for matu-
ration by incul)ation in 5 pg/mI pro-
gesterone (Prog. (. In ordler to exam-
ne the meiotic interphase (Mint,),
sve achievedl the synchronization of
maturing oo ytes by setting the
time of germinal vesicle breakdown
(GVBD(, determined by the ap-
pearance of a white 5001 in the an-
imal heniisphere, as “0” time, and
lysates were 1)r(’Paredl relative to
that time schedule. A, analysis of
Hi histone kinase activity diuring
meiotic interphase. The oocyte ly-
sates PreI)ar(’dI at each time point
were measured for MPF activity in
vitro using histone H 1 as a substrate
as described previously (79). The in
vitro kinase reaction mixtures were
analyzedi by 1 2/ SDS-PAGE. B,
immunoblot analysis of immuno-
precipitatedl p34’ “ 2 using anti-
phosphotyrosi n(’ (anti-P-Tyr) mono-
clonal antibody. The lysates were
immunoprecipitated with anti-
￿ ‘￿ 2 COcwi-terniinal peptide
antil)ody (Santa Cruz(. The immu-
noprecipitates were resolved by
12/ SOS-PAGE and transferred
onto Immohilon (Millipore) sheets.
The blots were then probed with
anli-P-Tyr monoclonal antibody
(PY-20(. Antibody-antigen complex
was delectedl by chemillumines-
cent reactions as described in the
Fig. 3 legend. C immunohlol anal-
ysis of MAPK during meiotic inter-
phase. The lysates resolvedi in iO#{176}k
SDS-PAGE were transferred onto
Immohilon )Millipore) sheets and
probed with anti-MAPK monoclo-
nal antibody (Zymed). Antibody-
antigen complex was dietected by
chemilluminescent reactions as de-
scribed in the Fig. 3 legendl. MAPK’
indicates the phosphorylated, ac-
five form of MAPK. 13, MPF (histone
Hi phosphorylalion( activity and
MAPK, in vitro MBP phosphoryla-
tion activity of anti-MAPK mono-
clonal antibody immunoprecipi-
tales, were also dluantitated by
scintillation counting and summa-
rized in (0).
Prog. GVBD M.int.
0 Q 0
blot analyses by ZSK2 were not tubulin molecules but were
reminiscent of the antigens detected with the M-specific
monoclonal antibodies, MPM-2 (48) and CHO3 (Ref. 49;
see below).
M-specific Phosphorylation during Interphase. The
monoclonal antibody MPM-2 reacts with phosphorylated
protein epitopes that are specifically modified during mito-
sis or meiosis but not during interphase (Refs. 48, 50, andA
B
0
4-
0
4.-
1098 max-induced M-phase Phenotypes in Somatic Cells
0
￿-
p
4.-21.5-
-
Cell Growth ￿ Differentiation 1099
A
Kd
MPM2
12345
200- ￿
I..
97.4-
￿
69 -
46 -
30 -
B CHO3
12345
￿ ￿
I ￿ ￿ #{163}
￿ . !-￿ ￿
.
-I.’
I ￿
4’
I: -
C ZSK2
12345
a
￿-
. ￿
_pI_I ￿
.￿;
Fig. 7. Immunoblot analysis of v-Mos-expressing cells with monoclonal antibodies directed against M-specific phosphoprotein epilopes. Cell extracts, prepared
as in the Fig. 1 legend and containing -50 pg of total protein, were run on a 6-i 2% gradient SOS-PAGE andl then transferredl onto Immobilon )Millipore) sheets.
The immunoblots were then probed with the monoclonal antibodlies: (A) MPM-2; (B) CHO3; and (C) ZSK2. Antibody-antigen (omplexes were detected with
horseradish peroxidase-conjugaledi anti-mouse lgG antil)odly (Boehringer Mannheim; for MPM2 and ZSK2( or anti-mouse 1gM antibodly )Boehringer Mannheim;
for CHO3(, followed I)y chemilluminescent reactions. Lane 1, control 3T3 cells; Lane 2. nocodlazole-arrested M-phase control 313 cells; Lane 3, floating cells;
Lane 4, Tx2 dells; Lane 5, Tx.) cells. The detection of M-phase antigens in cells expressing v.Mos (Lanes 3-5) was not due to a higher percentage of transformed
cells being in M-phase, since by flow cytometry analysis, v-rnos-transformedl cells show cell cycle phase distribution similar to contrd)l Swiss 3T3 cells (data not
shown(. More so than with the MPM-2 and CHO3 antibodies (Fig. 7 and data not shown), the ZSK2 antibodly is more reactive with antigens in cells expressing
v-Mos (Figs. 6 aridl 7) than M-phase control Swiss 3T3 cells.
Si ; Fig. 7A, compare Lanes 1 and 2). Like MPM-2, the ZSK2
and CHO3 antibodies also recognize epitopes that are sen-
sitive to alkaline phosphatase treatment (data not shown),
and all three antibodies react predominantly with M-spe-
cific phosphorylated epitopes (compare Fig. 7A, B, and C,
Lanes 1 and 2). Strikingly, with each of the monoclonal
antibodies, we found that antigens detected in the extracts
of the floating cells (Fig. 7A, B, and C, Lane 3) or v-mos-
transformed cell lines (Fig. 7A, B, and ￿, Lanes 4 and 5),
were very similar to those found in the M-arrested control
cells. However, low molecular weight antigens detected by
each antibody are more prevalent in the v-Mos-expressing
cells. We conclude that Mos expression induces M-specific
phosphoprotein modifications at all stages of the somatic
cell cycle.
Discussion
Our results suggest a model for transformation by the Mos
oncogene, whereby the program that is normally restricted
to the process of meiosis runs concurrently with the pro-
gram of the highly ordered somatic cell cycle, and the
degree of morphological transformation correlates with the
level of Mos and/or MAPK activation. At very high levels,
Mos expression in somatic cells induces MAPK activation,
growth arrest, binucleated cells,4 and inappropriate chro-
mosome condensation. Our studies also show that Mos
expression in somatic cells induces M phosphorylation
events at nonmitotic phases of the cell cycle. Davis et a!.
(52) have shown that MPM-2 antibody does not affect entry
into mitosis but blocks exit from mitosis, perhaps by pre-
Fig. 6. Indlirect immunofluorescence staining of v-Mos-expressing cells with monoclonal antibodies directed against o-tubulin andi M-phase phosphorylation-
dlependlent epit(ipes. A, cells either growing d)fl a coverslip (control IT 3 cells andl Tx3 v-rnos-transformed cells) or seededl on a coverslip by low speed
centrifugation (floating cells) were fixed andl immunostained with anti-c tubulin monoclonal antibody )DM1A(, followedi by a fluorescein isothiocyanate-
conjugatedl anti-mouse lgG antibodly (Amershani). a. control Swiss 3T3 cells; b, floating cells; c, Tx3 v-mos-transformed cells. x 630. B, cells were stained with
DAPI (d-t andl treatedl with monoclonal ZSK2 antibody )Zymed; a-cand g-j). The ZSK2 antibody-antigen complexes were detectedi using a Texas redl-conjugated
anti-mouse lgC antibody (Amersham(. a and d. the ZSK2 and DAPI staining of control 3T3 cells at interphase; b and e, c andl 1, control 3T3 cells during mitosis.
White arrosss, the mitotic cells dletectedi by condensed chromosomes (DAPI). ZSK2 dloes not efficiently stain the interphase cells. ZSK2 stained Mo-MuSV-infected
cells at 4)) h P.1. (g(, floating cells (h(, Tx3 v-rnos-transformed cells (i), andl Tx2 v-rnos-transformed cells )j( indlependent of their cell cycle stages. x 250.1100 mos-induced M-phase Phenotypes in Somatic Cells
U, K. Fukasawa and N. G. Ahn, unpublished observations.
venting the dephosphorylation of the M-specific antigens.
The high levels of v-Mos could induce growth arrest by
preventing sufficient dephosphorylation of certain M-spe-
cific antigens to allow cell cycle progression.
In the floating cells, in spite of the presence of dephos-
phorylated p34cdc2 and cyclin B, histone Hi kinase activity
is not detectable, although the floating cells display chro-
mosome condensation. This phenotype may be similar to
oocytes during meiotic interphase, when MPF is low, but
the chromosomes remain condensed (53), and the levels of
Mos and MAPK are high. These kinases and the cascade of
kinases and phosphorylation events they regulate may be
sufficient to maintain growth arrest and chromosome con-
densation. MAPK is activated by Mos (25, 26) and is local-
ized to MTOCs present at the poles and kinetochores of the
meiotic spindles. Recently, Mos has been localized to kin-
etochores (54). Moreover, both MPM-2 and CHO3 mono-
clonal antibodies that constitutively recognize M-phase an-
tigens in cells expressing Mos also stain MTOCs at mitotic
spindle poles and kinetochores (55-58), and at least some
MPM-2 and CHO3 epitopes are generated by MAPK during
meiosis (59). Furthermore, using partially purified microtu-
bules from Swiss 3T3 cells as a substrate for MAPK in vitro,
at leastone high molecular weight protein (Mr 230,000) is
phosphorylated and becomes an epitope for MPM-2 and
CHO3 monoclonal antibodies.6 It is possible, therefore,
that Mos expression in somatic cells either directly or, more
likely, through activating a cascade of specific kinases that
are normally restricted to meiotic maturation such as MAPK
and possibly Raf(60, 61), promotes the inappropriate phos-
phorylation of M-phase epitopes at all stages of the cell
cycle.
Boveri (62) first implicated defective spindle poles as a
causative factor in malignant tumors, and binucleated tu-
mor cells were one of the earliest unexplained histopatho-
logical observations found in Mo-MuSV-induced mouse
sarcomas (63). Cells transformed by v-mos have been
shown to be genetically unstable (64), and genetic instabil-
ity is a component of tumor cell progression. The sister
chromatid exchange and chromosome segregation that
uniquely occur during meiosis is likely to use different
checkpoint functions for fidelity than somatic cells (65).
Superimposing a meiotic program on a mitotic cell cycle
could possibly influence and compromise somatic cell
checkpoint function. Other oncogenes such as ras (16,
66-68) and raf(60, 61) induce meiotic maturation, and all
activate MAPK (69-72). Constitutive activation of MAPK is
a property common to many oncoproteins; therefore, the
MAPK family of proteins (73-75) would make ideal down-
stream targets for clinical intervention.
Materials and Methods
Cells. Swiss 3T3 cells used in this study were maintained in
complete medium (Dulbecco’s modified Eagle’s medium-
10% fetal bovine serum with 100 units/mI penicillin and
100 pg/mI streptomycin) and grown in an atmosphere con-
taming iO% CO2. Cultures were maintained at a subcon-
fluent density by passing 7.5 x i05 cells per 100-mm dish
twice weekly.
Virus and Virus Infedion. Mo-MuSV 124 is a clonal
isolate from the original Mo-MuSV stock (76). Twenty-four
h before infection,i x i06 Swiss 3T3 cells were plated per
100-mm dish with complete medium containing 4 pg/mI
Polybrene; followed by a 1-h incubation period with fil-
tered medium from either Mo-MuSV i 24-transformed pro-
ducer cells (TB cell line) or Mo-MuLV producer cells, also
containing 4 pg/mI Polybrene. The multiplicities of infec-
tion were typically 5-iO focus-forming units per cell for
both Mo-MuSV 124 and Mo-MuLV. Mock-infected cells
were treated identically, except that no virus was added.
After infection, the cells were cultured in complete me-
dium.
Immunoblotting. Cells were washed twice in PBS and
then lysed in modified sample buffer [2% SDS, 10% glyc-
erol, and 60 mM Tris (pH 6.8)1. Cell extracts were cleared by
a 30-mm centrifugation at 100,000 X g. The lysate dena-
tured at 95#{176}C for 5 mm in sample buffer [2% SDS, iO%
glycerol, 60 mt￿i Tris (pH 6.8), 5% f3-mercaptoethanol, and
0.Oi % bromophenol blue]. Samples were resolved by SDS-
PAGE. Fractionated proteins were then transferred to Im-
mobilon (Millipore) sheets, and the blots were incubated in
blocking buffer [5% (w/v) nonfat dry milk-0.2% Tween 20
in TBS)] for 2 h at room temperature and then with primary
antibodies for 2 h at room temperature. The blots were
rinsed in TBS-T (0.2% Tween 20 in TBS) and incubated with
either alkali ne phosphatase-conj ugated or horserad ish per-
oxidase-conjugated secondary antibodies for 1 h at room
temperature. The blots were then rinsed in TBS-T, and the
antibody-antigen complex was visualized with either bro-
mochloroindolyl phosphate (Bio-Rad) and nitroblue tetra-
zolium (Bio-Rad) as substrates in 100 m￿i NaCI-5 ms’t
MgCl2-iOO mM Tris (pH 9.5) for the alkaline phosphatase
reaction or visualized by using the ECL chemiluminescence
method (Amersham), according to the manufacturer’s in-
structions for horseradish peroxidase reaction.
Indired Immunofluorescence. Cells, either seeded on
slides by low speed centrifugation or grown on coverslips,
were washed twice with PBS and then fixed with 3.7%
formaldehyde for 20 mm at room temperature. After fixa-
tion, the cells were washed with PBS and permeabilized
with 1% Nonidet P-40 in PBS for 5 mm at room tempera-
ture. Coverslips were incubated with blocking solution
(1 0% normal goat serum in PBS) for i h and then incubated
with primary antibodies, followed by incubation with either
fluorescein isothiocyanate or Texas red-conjugated second-
ary antibodies for 1 h at room temperature. Coverslips were
washed three times with PBS after each incubation. Cover-
slips were then embedded in aqueous nonfluorescing
mounting medium.
Ceneration and Preparation of Floating Cells. Over the
period of 72 h after infection of Swiss 3T3 cells with Mo-
MuSV, ￿90% ofthe cells round up and float into the media
(floating cells). The floating cells were directly collected
from the cell culture media. The examination of their via-
bilities by trypan blue exclusion assay showed that -70%
ofthe floating cells were viable (excluding trypan blue), and
-30% were dead or dying. The ratio of viable to dead or
dying cell populations are constant in repeated experiments
with the SE of less than 5%. When replated into fresh media,
the floating cells remain viable for at least 1 week.4
Histone Hi Kinase Analysis. Cell extracts containing
-300 pg total protein were incubated with 25 p1 pi3sU1￿
beads (Oncogene Science) for 3 h at 4#{176}C. The beads were
collected, washed five times with lysis buffer [1 50 m￿
NaCI, 50 mM Tris (pH 7.5), i mtvi EDTA, i % Nonidet P-40,
1 mM DTT, 50 mM NaF, 1 misi Na3VO4, 2.5 mivi PMSF, 2Cell Growth & Differentiation 1101
pg/mI leupeptin, 2 pg/mI aprotinin)l, and resuspended in 20
p1 histone Hi kinase buffer [80 ms’i sodium ￿-glycerophos-
phate, 20 mM EGTA, 50 mtvt MgCI2, 20 msi N-2-hydroxy-
ethylpiperazine-N’-2-ethanesulfonic acid (pH 7.2), 1 mivt
DTT, 2.5 mM PMSF, 2 pg/mI leupeptin, 2 pg/mI aprotinin,
and 10 ￿M protein kinase A inhibitor (Sigma Chemical Co.)].
Histone Hi kinase assay was performed by adding i 2 p1 of
a mixture containing i mg/mI histone Hi, i mr’￿i ATP, and
i pCi [y-32P]ATP. The reaction was incubated at room
temperature for i 5 mm and stopped by the addition of 30 p1
2X sample buffer 1100 mist Tris-CI (pH 6.8), 4% SDS, 20%
glycerol, 10% ￿-mercaptoethanol, and 0.2% bromophenol
blue)].
MAP Kinase Analysis. Cells were washed twice in PBS
and then lysed in Triton X-1 00 buffer [1 % Triton X-i 00,
0.1% SDS, 50 mM Tris (pH 8.0), 50 ms￿i f3-glycerophos-
phate, 50 mM sodium fluoride, 5 ms’i MgCI2, 1 mivi Na3VO4,
i mM DTT, i 0 mM EGTA, 2.5 m M PMSF, i 0 pg/mI leupep-
tin, and 10 pg/mI aprotinin] by incubation for 30 mm on
ice. The cell lysates were cleared by centrifugation for 30
mm at 100,000 X g at 4#{176}C. The lysate containing -1 00 pg
of total protein was immunoprecipitated with anti-MAP
kinase antibody i9i3 (77). Antibody-MAPK complex was
collected with protein-A agarose beads and washed five
times with Triton X-iOO buffer and once with histone Hi
kinase buffer. The MAPK activity was measured using MBP
as a substrate. The assay was performed in 30 p1 of histone
Hi kinase buffer containing MBP (i mg/mi), 2 pCi [y32-
PIATP, and i 0 pm ATP. After i 5 mm at room temperature
followed by incubation at 30#{176}C for i 5 mm, the reaction was
stopped by the addition of 30 p1 2X sample buffer. MBP
phosphorylation activity of maturing oocytes were assayed
as described previously (78).
Colony Formation in Soft Agar. Analysis of v-mos-trans-
formed cell lines for anchorage-independent growth was
performed in 60-mm dishes by overlaying i 0￿ cells in
Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum, 0.3% (w/v) Noble agar (Difco), and 0.1 2%
Bactopeptone onto a base of 0.5% (w/v) Noble agar and
0.2% Bactopeptone prepared in the same medium. Cob-
nies were allowed to grow for 2 weeks at 37#{176}C in an
atmosphere containing i 0% CO2.
Oocyte Preparations. Xenopus !aevis females were pur-
chased from Xenopus i (Ann Arbor, Ml). Oocytes were
surgically removed and defolliculated by incubation in
modified Barth solution [88 misi NaCI, i mt￿i KCI, 2.5 m￿i
NaHCO3, 10 mM N-2-hydroxyethylpiperazine-N’-2-eth-
anesulfonic acid (pH 7.5), 0.82 ms’t MgSO4, 0.33 mtvi
Ca(NO3)2, and 0.4i mM CaCI2] containing collagenase A
(i .5 mg/mI; Boehringer Mannheim Biochemicals) for 2 h at
20#{176}C. The oocytes were washed extensively in modified
Barth solution, and stage VI oocytes were selected and
allowed to recover i 6 h in 50% Leibovitz’s L-i 5 medium
(GIBCO). Oocyte maturation was induced by incubation in
5 pg/mI progesterone (Calbiochem) in 50% L-i 5 medium.
Percoll Cradient Separation. The gradient was devel-
oped in PBS (90% Percoll solution and 10% PBS) by cen-
trifugation for i 5 mm at 23,000 X g in a fixed-angle rotor.
The cells collected from the culture dish (--i X i06 cells)
were resuspended in 4 ml of complete medium. The cell
suspension was applied onto the Percoll gradient and sub-
jected to centrifugation for 15 mm at 600 x g, followed by
centrifugation for 30 mm at i 000 X g. More than 95% of
the cells in the band formed after centrifugation consisted of
viable cells, while cells diffused in the upper layer almost
exclusively consisted of dead or dying cells.
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